Susquehanna International Group, LLP Arca Biopharma, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 16, 2023
BUY
$1.99 - $2.55 $46,964 - $60,179
23,600 Added 51.42%
69,500 $138,000
Q4 2022

Feb 14, 2023
SELL
$1.86 - $25.8 $1.51 Million - $20.9 Million
-810,400 Reduced 94.64%
45,900 $108,000
Q3 2022

Nov 14, 2022
SELL
$2.13 - $25.68 $56,658 - $683,088
-26,600 Reduced 3.01%
856,300 $1.76 Million

Others Institutions Holding ABIO

# of Institutions
37
Shares Held
13M
Call Options Held
41.6K
Put Options Held
5.6K
View Full List

About ARCA biopharma, Inc.

ABIO Quotes by TradingView
  • Ticker ABIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,410,100
  • Description
  • ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...
More about ABIO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email